Motilal Oswal has released its recommendations on three stocks amid the sharp rally across the market. The brokerage house sees an upside potential of up to 13% in one of these stocks. Read more to know about the stocks and the reasons powering he rating and the target price.
Motilal Oswal on Larsen & Toubro: Strong international project pipeline
Motilal Oswal raised the target price on Larsen & Toubro to Rs 4,100, looking at an upside of 13% over the next 12 months. It has a ‘Buy’ rating on the stock. According to the report, L&T’s annual report of 2025 highlighted its consistent focus on diversifying revenue streams, exploring new opportunities and enhancing return profile.
The brokerage expects L&T to benefit from the strong international prospect pipeline, a low base of domestic ordering last year, an improved RoE profile, and better capital allocation over the past few years. The company’s near-term ordering may be affected by the Israel-Iran conflict in the Middle East and fluctuating oil prices, but the long-term support is still intact.
Motilal Oswal on Piramal Enterprises: Shift towards retail franchise gaining attraction
Motilal Oswal has a ‘Neutral’ rating on Piramal Enterprises, with a target price of Rs 1,250, which is an upside of 11% from the current market price. The company’s strategic shift towards building a granular and diversified retail franchise, alongside a calibrated wholesale book, continues to gain traction.
The company has demonstrated steady progress on asset quality, with volatility largely behind and credit costs expected to remain stable. With new product launches such as co-branded credit cards and gold loans in the pipeline, the company is expanding its fee income base and diversifying its earnings profile.
Motilal Oswal on Alkyl Amines Chemicals: Management cautiously optimistic
The brokerage firm has a ‘Neutral’ call on Alkyl Amines and has a target price of Rs 2,110. This is a slight downside from the current market price. The company’s management remained cautiously optimistic, leveraging strong domestic leadership and expanded capacities to drive scalable growth. However, pricing pressure from imports and certain commoditised products poses risks
While short-term challenges persist from low-cost imports, anti-dumping duties are expected to help margin recovery and market share in the second half of FY26. The speciality chemical firm increased its R&D spend to Rs 8.9 crore in FY25 (0.6% of sales), focusing on new product development, process efficiency, and sustainability.